Hormone replacement therapy and intima-media thickness of the common carotid artery: the Rotterdam study

I C Westendorp1, B A in 't Veld, M L Bots

  • 1Departments of Epidemiology and Biostatistics, Erasmus University Medical School, Rotterdam, The Netherlands.

Stroke
|December 3, 1999
PubMed

Insights

Hormone replacement therapy (HRT) use for over one year was linked to reduced carotid artery intima-media thickness (IMT) in postmenopausal women. This suggests HRT may inhibit atherosclerosis, a key factor in cardiovascular disease.

Area of Science:

  • Cardiovascular Health
  • Endocrinology
  • Gerontology

Background:

  • Observational data indicate hormone replacement therapy (HRT) may reduce cardiovascular disease morbidity and mortality in postmenopausal women.
  • Potential mechanisms include inhibition of the atherosclerotic process.

Purpose of the Study:

  • To investigate the association between HRT use and intima-media thickness (IMT) of the common carotid artery.
  • To explore the relationship between HRT duration and IMT in elderly women.

Main Methods:

  • A population-based cohort study (Rotterdam Study) involving 1103 naturally menopausal women aged 55-80.
  • Noninvasive B-mode ultrasound was used to measure mean and maximum IMT of the common carotid artery.
  • Statistical analysis adjusted for age, smoking, educational level, blood pressure, and BMI.

Main Results:

  • Ever use of HRT for >= 1 year was significantly associated with decreased mean IMT (0.719 mm vs. 0.742 mm, P=0.03) and maximum IMT (0.952 mm vs. 0.983 mm, P=0.04).
  • No significant association was found for HRT use < 1 year.
  • Adjustments for diabetes, healthcare visits, and cholesterol levels did not alter the findings.

Conclusions:

  • Ever use of hormone replacement therapy is associated with reduced intima-media thickness in the common carotid artery of elderly women.
  • This finding supports a potential role for HRT in mitigating atherosclerotic changes.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...